dCELL® Technology

Our unique, patented dCELL® Technology is revolutionising the treatment of complex and unmet clinical needs 

dCELL® Technology

Our unique, patented dCELL® Technology is revolutionising the treatment of complex and unmet clinical needs 

The Power of dCELL® Technology

dCELL® Technology offers a unique approach to regenerative medicine.

The dCELL Technology process is gentle and efficient — and powerful: It produces allograft and xenograft tissue matricses that retain the native collagen structure, and an intact acellular matrix.

The dCELL® process removes cellular and DNA material from biological tissues, through a patented series of gentle washes, leaving intact an acellular matrix upon which the patient's cells can regenerate and re-populate, so that new tissue is created which is recognized and accepted by the body, rather than being at risk of rejection.

dCELL® Technology provides  an enhanced healing environment, in terms of both natural, tissue-specific physical structure and biomechanical properties. Grafts made using dCELL® Technology give the patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength.  This allows the remodelling process to occur, allowing the graft to become a part of the patients own tissue. 

 Currently Tissue Regenix is focusing on addressing complex and unmet clinical needs in wound care, orthopaedics and heart valve replacement. 

dCELL® Technology: How it works